If you will not inject

For a lot of people the needle is the whole barrier, and until recently the alternatives were compounded sublingual products of varying quality. That changed in 2026.

Two oral GLP-1s are now FDA-approved and start at $149 a month self-pay — less than a large share of the compounded injection programmes we track. They deserve consideration before any compounded oral product.

What qualifies for this list

• Offers an oral tablet or sublingual formulation alongside or instead of injections.
• The FDA-approved oral options are covered separately at the top of the page.
• Ranked on the full rubric.

5 of the 21 providers we track qualify. Prices verified 2026-09-18 and re-checked periodically.

The list

Cheapest qualifying option: LifeMD at $149 a month. Our featured partner is pinned to the top of the list where it qualifies — see how we rate for who scores higher.

1. PlexusDx — Pharmacy transparency and genetic testing

$189 a month, no membership fee. Prescription GLP-1 and peptide programmes with no membership fee, built around genetic testing, using independent clinicians and a publicly listed set of 503A pharmacies.

The advertised "from $129" is the programme floor. Budget $189/month for the compounded injection tier. Read the full PlexusDx review.

2. Hims & Hers — Widest range of formats

$238 a month, including the $39 fee. Large publicly traded telehealth platform. Sells oral kits, compounded injections and branded Zepbound side by side, with a membership required across the board.

The advertised entry prices and the membership are separate charges. Add $39/month to whatever medication figure you were quoted. Read the full Hims & Hers review.

3. LifeMD — Insurance coordination

$149 a month, no membership fee. Physician-led telehealth group with a weight-management programme built around insurance coordination and branded prescriptions.

If your insurer declines, the $149/month programme fee still applies and the medication is extra. Read the full LifeMD review.

4. Henry Meds — Sublingual and oral formats

$449 a month, no membership fee. Compounded GLP-1 provider with a strong oral and sublingual line alongside weekly injections, sold in monthly and prepaid multi-month blocks.

The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month. Read the full Henry Meds review.

5. MEDVi — Tablet and injection choice

$399 a month, no membership fee. Compounded GLP-1 provider offering weekly injections and a tablet formulation, with tablet pricing quoted after intake rather than published.

You have to complete intake before seeing tablet pricing. Injection pricing is published at $399. Read the full MEDVi review.

Common questions

Are oral GLP-1s as effective as injections?

The approved oral products have their own trial data and are genuinely effective, but injectable tirzepatide still produced the largest average weight loss of any option in head-to-head testing. Compounded sublingual products do not have equivalent trial evidence.

What are the approved pills?

The Wegovy pill (oral semaglutide), approved in late 2025 and launched January 2026, and Foundayo (orforglipron), approved 1 April 2026. Both start around $149 a month self-pay.

Is oral semaglutide difficult to take correctly?

It has strict instructions — an empty stomach, a small sip of water, and a wait before eating or taking anything else. Get that wrong and absorption suffers. Orforglipron does not carry the same restriction.